• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Department of Ophthalmology, University of Medicine Cluj-Napoca, Cluj-Napoca - Romania.

出版信息

Eur J Ophthalmol. 2017 May 11;27(3):e104-e105. doi: 10.5301/ejo.5000898.

DOI:10.5301/ejo.5000898
PMID:27768225
Abstract
摘要

相似文献

1
Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.致编辑的信：贝伐单抗治疗后雷珠单抗用于持续性糖尿病黄斑水肿
Eur J Ophthalmol. 2017 May 11;27(3):e104-e105. doi: 10.5301/ejo.5000898.
2
Author's reply to comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.
Eur J Ophthalmol. 2017 May 11;27(3):e106. doi: 10.5301/ejo.5000900.
3
Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.比较玻璃体内注射贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿。
J Ocul Pharmacol Ther. 2011 Aug;27(4):373-7. doi: 10.1089/jop.2010.0195. Epub 2011 Jun 1.
4
A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.一项玻璃体内注射贝伐单抗与雷珠单抗治疗糖尿病黄斑水肿的前瞻性随机试验。
Am J Ophthalmol. 2013 Sep;156(3):502-510.e2. doi: 10.1016/j.ajo.2013.04.026. Epub 2013 Jun 21.
5
Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.雷珠单抗用于贝伐单抗治疗后持续性糖尿病性黄斑水肿
Eur J Ophthalmol. 2017 Mar 10;27(2):210-214. doi: 10.5301/ejo.5000838. Epub 2016 Jul 18.
6
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.阿柏西普、贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿的比较：数据外推至临床实践
JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110.
7
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.血管内皮生长因子在年龄相关性黄斑变性和糖尿病性黄斑水肿患者玻璃体内注射贝伐单抗、雷珠单抗和聚乙二醇化阿柏西普前后的血浆水平。
Br J Ophthalmol. 2013 Apr;97(4):454-9. doi: 10.1136/bjophthalmol-2012-302451. Epub 2013 Feb 5.
8
Emergency department visits after intravitreal bevacizumab and ranibizumab injections in diabetic patients.糖尿病患者玻璃体内注射贝伐单抗和雷珠单抗后的急诊科就诊情况。
Can J Ophthalmol. 2014 Dec;49(6):e146-8. doi: 10.1016/j.jcjo.2014.08.018.
9
RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS.雷珠单抗治疗对多种先前治疗均耐药的糖尿病性黄斑水肿
Retina. 2016 Jul;36(7):1292-7. doi: 10.1097/IAE.0000000000000876.
10
Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept.玻璃体内注射阿柏西普治疗对贝伐单抗或雷珠单抗耐药的糖尿病性黄斑水肿患者：对阿柏西普反应的分析
Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):250-255. doi: 10.22608/APO.2016186. Epub 2017 Apr 10.

引用本文的文献

1
Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。 （原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）
Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.
2
Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.将治疗方案从贝伐单抗转换为阿柏西普以治疗持续性糖尿病性黄斑水肿。
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1451-1452. doi: 10.1007/s00417-017-3669-y. Epub 2017 Apr 7.